A beta-glucan compound capsule structure

Abstract

A beta-glucan compound capsule comprising: a capsule body, wherein the capsule body comprises a first capsule shell and a second capsule shell, the first capsule shell having a first opening at one end and a rounded first closure at the other end, with a first snap-in structure on the outer edge; the second capsule shell is transparent, with a second opening at one end and a circular second closed end at the other end, with a second snap-in structure on the inner edge, wherein the first opening of the first capsule shell and the second opening of the second capsule shell interlock, and wherein the first snap-in structure and the second snap-in structure interlock to form a closed receiving space;and a content housed in the receiving chamber, the composition of which comprises β-polydextrose, glutamic acid, Lactobacillus paracasei, zinc glycosaminoglycate, selenium yeast, magnesium stearate and silicon dioxide.

Description

Technical FieldThe present invention relates to a capsule structure, particularly a beta-glucan junction capsule structure.Background TechnologyImmunity is the ability of the human body to resist diseases and is the immune system performing this important function. The human immune system has three major functions: 1. immune defense: When pathogenic microorganisms attack the body, the immune system can recognize and resist these foreign disease causing substances, thus maintaining health. 2. immune monitoring: The immune system can timely recognize and remove mutated cells in the body to reduce the risk of their development into tumors. 3. immune stabilization: The immune system can remove its own metabolites in time and thus prevent them from accumulating and causing diseases. 3. immunological stabilization: The immune system is capable of eliminating its own metabolites in good time and thus preventing them from accumulating and triggering autoimmune diseases. From these three functions it is apparent that the immune system is an important line of defense for maintaining health and that weak immunity is directly manifested in susceptibility to diseases. As pathogens enter the body, a powerful immune system can excite the "body's own self-healing forces" to effectively distribute the pathogens and promote recovery of the body's health.The human immune system is a complex and organic entity. Under normal conditions, the immune system is able to self-regulate to prevent autoimmune diseases by preventing infection by foreign pathogens, destroying cancer cells, and timely removing reactive lymphocytes. Malfunction of the immune system, however, can result in a variety of diseases, including autoimmune diseases, immunodeficiency diseases, infections, and tumors. In the development of infectious diseases and tumors, decreased immunity is one of the most important triggers.After examining the world health organization, about 50% of the world population is immunocompromised and there is an urgent need to improve immunity. As economic globalization accelerates, people's rhythms of life become more and more rapid. Long working times, increased psychic pressure and irregularities in life have led to the increase in the number of people with low immunity year by year. Therefore, the strengthening of human immunity has become one of the most important issues that the present society has to pay attention.Beta glucan is a natural polysaccharide widely used in cereals, yeast and some fungi. Studies have shown that beta glucan has various biological activities and effectively regulates immune function.However, the β-glucan products on the market are still insufficient in absorption rate and stability, and their health effects must be further improved. Moreover, the capsule design of the existing products is not only cumbersome to assemble, but also prone to unstable pushbuttons, which increases the risk of falling out.Content of the Utility ModelIn view of the above problems, the user of this work came the idea of creation. After many discussions and trial, as well as many corrections and improvements, the present utility model has been devised.The present invention is a beta glucan junction capsule comprising: a capsule body comprising a first capsule shell and a second capsule shell having a first opening at one end of the first capsule shell and a rounded first closed end at the other end. The first capsule shell has a first opening at one end and a rounded second closed end at the other end, and a second snap structure is provided at the inner edge. The first opening of the first capsule shell and the second opening of the second capsule shell are joined, and the first snap structure and the second snap structure are joined to form a closed accommodation space; and a content accommodated in the accommodation space, wherein the composition of the content comprises β-polydextrose, glutamic acid, Lactobacillus paracasei, zinc glyceroaminoglycate, selenium yeast, magnesium stearate, and silica.The utility model of the present beta-glucan connecting capsule is that the first capsule shell and the second capsule shell can be securely and firmly connected to each other so that the contents can be entirely obtained inside the capsule body. Since the second capsule is transparent, it is easy to visually confirm the snap status of the first snap structure and the second snap structure, which simplifies the assembly process, reduces the risk of dropping and ensures the stability and effectiveness of the content, and also the assembled formulation of the content is capable of effectively regulating the immune function.DESCRIPTION OF THE ACCOMPANYING DRAWINGSFig. 1 is a three-dimensional drawing of this utility model. Fig. 2 is a three-dimensional division of this utility model. Fig. 3 is the planar disassembly of the utility model. FIG. 4 is a sectional view of the first capsule shell and the second capsule shell of the utility model. Fig. 5 is a plan view of this utility model. FIG. 6 is a sectional view taken along line A-A of FIG. 5. FIG. 7 is the enlarged part A 1 of FIG. 6.In the figures: 10th capsule body; 11th first capsule shell; 111. First opening; 112. First closed end; 113. concave ring section; 12. second capsule shell; 121. Second opening; 122. Second closed end; 123th convex ring portion; 13th enclosing space; 20th content; 21st β-glucans; 22nd glutamic acid; 23rd Lactobacillus paracasei; 24th zinc glycosaminoglycan; 25th selenium yeast; 26th magnesium stearate; 27th silica; D1. Alum diameter; D2. Inner DiameterDetailed DescriptionA further description of a preferred embodiment of the present invention will follow to enable those familiar with the technology of the present invention to practice the invention as described in the specification.As shown in Figs. 1 to 7, the β-polyglucose compound capsule of the present invention first comprises a capsule body 10 and a contents 20.The capsule body 10 comprises a first capsule shell 11 and a second capsule shell 12.The first capsule shell 11 is made of edible material, the first capsule shell 11 has a circular cross section, a first opening 111 at one end and a first closed end 112 in a circular arc at the other end, and the first capsule shell 11 is provided with a first snap structure at the outer periphery. The first opening 111 has an outer diameter D 1, and in this embodiment, the first snap structure is a concave ring portion 113 disposed near the first opening 111, and the concave ring portion 113 has a concave arc-shaped cross section.The second capsule shell 12 is made of an edible material and is transparent, the second capsule shell 12 also has a circular cross section, a second opening 121 at one end and a second closed end 122 at the other end, and the second opening 121 is provided with a second snap structure at the outer edge. The second opening 121 has an inner diameter D 2 that is approximately equal to the outer diameter D 1 of the first capsule shell 11. In this embodiment, the second snap structure is a convex ring portion 123 provided in the central portion of the second capsule shell 12, and the convex ring portion 123 has the shape of a convex arc.The first opening 111 of the first capsule shell 11 and the second opening 121 of the second capsule shell 12 are fitted to each other, and the concave ring portion 113 of the first capsule shell 11 and the convex ring portion 123 of the second capsule shell 12 are fitted to each other to form a stable and firm connection. Accordingly, an enclosing space 13 is formed between the first capsule shell 11 and the second capsule shell 12, and during the mutual matching process, the seating status of the concave ring portion 113 and the convex ring portion 123 can be visually inspected through the transparent second capsule shell 12.The contents 20 are in powder form and contained in the enclosing space 13, and the composition of the contents 20 comprises β-glucans 21, glutamic acid 22, Lactobacillus paracasei 23, zinc glycosaminoglycan 24, selenium yeast 25, magnesium stearate 26, and silica 27. the β-glucans 21 as a main component have an effect of strengthening the immune system, the glutamic acid 22 aids in cell repair and regeneration and enhances the immune function, the Lactobacillus paracasei 23 is a probiotic component promoting intestinal health, and the zinc glycosaminoglycan 24 contributes to improving the function of the immune system. The selenium yeast 25 is rich in selenium and aids in antioxidant and immunological control, the magnesium stearate serves as an anticaking agent to ensure the liquid of the contents, and the silica is used to improve the stability and liquid of the capsule.When consuming the utility model β-polyglucose compound capsule, consumers can adjust the dosage according to their own health and according to the recommendation of the physician, generally, for adults, it is recommended to consume 2 capsules per day after meals, and upon consumption, the capsule can be opened to soak the powder in water or to put it in milk.From the structure of the above-mentioned specific embodiments, the following advantages can be obtained:A beta-glucan connection capsule of the present invention ensures the complete preservation of the contents 20 by the close connection of the first capsule shell 11 and the second capsule shell 12. Moreover, the second capsule shell 12 is transparent, which facilitates visual inspection by the user to easily confirm the snap status of the first snap structure and the second snap structure, which not only simplifies the assembly process but also greatly reduces the risk of slipping, thereby ensuring the stability and effectiveness of the contents 20. Moreover, the formula of the composite capsule contents 20 has been carefully designed to effectively regulate immune function, and these functions make it an ideal health supplement, particularly suited for humans who must improve their immune and metabolic health.

Claims

A beta-glucan junction capsule comprising: a capsule body, the capsule body comprising a first capsule shell and a second capsule shell, wherein the first capsule shell has a first opening at one end and a rounded first closure at the other end, with a first snap structure at the outer rim; the second capsule shell is transparent, with a second opening at one end and a circular second closed end at the other end, with a second snap structure at the inner rim, wherein the first opening of the first capsule shell and the second opening of the second capsule shell fit together, and wherein the first snap structure and the second snap structure fit together to form a closed receiving space; and a content accommodated in the accommodation space, wherein the composition of the content comprises β-polydextrose, glutamic acid, Lactobacillus paracasei, zinc glyceroaminoglycate, selenium yeast, magnesium stearate and silica.A beta-glucan junction capsule according to claim 1, wherein the first snap structure is an annular concave portion, the annular concave portion being disposed near the first opening, and the second snap structure comprises an annular convex portion; the annular convex portion is disposed at the central part of the second capsule shell, and the annular concave portion of the first capsule shell and the annular convex portion of the second capsule shell snap together.A beta-glucan junction capsule according to claim 1, wherein the first capsule shell and the second capsule shell have a circular cross-section.A beta-glucan junction capsule according to claim 1, wherein the first opening of the first capsule shell has an outer diameter, the second opening of the second capsule shell has an inner diameter, and wherein the outer diameter of the first opening and the inner diameter of the second opening are substantially the same.A beta-glucan junction capsule according to claim 1, wherein the content is in powder form.

Images